Author

Y.-H. Xu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Nidamangala Srinivasa· 1 shared C. Wang· 1 shared G.-S. Jia· 1 shared I. M. Sabbarini· 1 shared J. J. Lange· 1 shared K. Li· 1 shared L. Zhao· 1 shared L.-L. Du· 1 shared

Activity by Year

2017-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEvolutionary Biology

A. Nidamangala Srinivasa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The wtf meiotic driver gene family has unexpectedly persisted for over 100 million years

M. De Carvalho, G.-S. Jia, A. Nidamangala Srinivasa, R. B. Billmyre, Y.-H. Xu, J. J. Lange, I. M. Sabbarini, L.-L. Du, S. E. Zanders

This study identifies the persistence of the wtf meiotic driver gene family across four fission yeast species diverging over 100 million years ago, showing that active meiotic drive systems can persist long-term.

bioRxiv · Jun 24, 2022Evolutionary Biology

Harnessing the Cross-talk between Tumor Cells and Tumor-associated Macrophages with a Nano-drug for modulation of Glioblastoma Immune Microenvironment

T.-F. Li, K. Li, C. Wang, X. Liu, Y. Wen, Y.-H. Xu, Q. Zhang, Q.-Y. Zhao, M. Shao, Y.-Z. Li, M. Han, N. Komatsu, L. Zhao, X. Chen

This study demonstrates that Nano-DOX-loaded TAM can reprogram GBM cells to an anti-GBM phenotype through DAMP emission, enhancing immune response and reducing tumor growth.

Journal of Controlled Release · Dec 1, 2017Peer-reviewedPharmacology & Toxicology